HOME >> BIOLOGY >> NEWS
Other highlights in the Jan. 17 JNCI

Calcium Supplements Offer Prolonged Protection Against Colorectal Adenomas in High-Risk Patients

Previous studies have shown that people with noncancerous colorectal tumors called adenomas who take calcium supplements for 4 years can reduce their risk of an adenoma recurrence. A new study shows that the protective effect of those supplements lasts for up to 5 years after stopping supplementation.

In the Calcium Polyp Prevention Study, 930 people with a recent adenoma were randomly assigned to receive 4 years of daily 1200-milligram calcium supplements or a placebo. The study revealed that those assigned to calcium supplements had a 17 percent lower relative risk of an adenoma recurrence than those who got the placebo.

In the new study, Maria V. Grau, M.D., and John A. Baron, M.D., of Dartmouth Medical School, and colleagues followed 822 of the patients from that trial after the end of the treatment. Their aim was to compare the risk of recurrence among participants who had taken calcium with the risk among those who had taken a placebo.

The researchers found that, in the first 5 years after the end of the treatment, people in the calcium group continued to have a lower risk of adenomas than those in the placebo group: 31.5 percent of people who had taken calcium had recurrences compared with 43.2 percent of those originally in the placebo group. However, after 5 years, this protective effect disappeared.

"Our study provides further evidence of the potential of calcium as a chemopreventive agent against colorectal adenomas among individuals with a history of these tumors," the authors write. "Our data indicate that, in these patients, the protective effect of calcium may extend for up to 5 years after the cessation of active treatment."

"Where do we go from here--and, more important, what public health recommendations related to calcium do we provide for risk reduction of colorectal cancer?" ask ed
'"/>

Contact: Andrea Widener
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
16-Jan-2007


Page: 1 2 3 4 5 6 7

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Other highlights from the April 18 Journal of the National Cancer Institute
9. Other highlights from the March 21 JNCI
10. Other highlights in the March 7 JNCI
11. Other highlights in the Feb. 21 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... (PRWEB) , ... August 16, 2018 , ... With increasing ... execution of basic research projects, are presenting multiple challenges. To be successful in such ... to execute the different aspects of the multiple tasks needed to develop a new ...
(Date:8/17/2018)... ... 16, 2018 , ... Cryo-Cell International, Inc. (OTC:QB Markets Group ... and store stem cells in 1992, announced that Arthur Ellis, JD, Board President ... and Managing Partner IsZo Capital, have joined the Company’s Board of Directors. , ...
(Date:8/15/2018)... ... ... The Florida Chiropractic Association’s National Meeting on August 16th-19th in Orlando, ... U.S. will gain firsthand insights into the new laser’s advancements and superior treatment abilities. ... trial that has resulted in the granting of an FDA 510(k) market clearance for ...
Breaking Biology News(10 mins):
(Date:8/26/2018)... ... August 24, 2018 , ... ExoCoBio ... exosomes dramatically relieves atopic dermatitis and inhibits a variety of inflammatory targets in ... paper, the symptoms of mice having severe atopic dermatitis were significantly improved after ...
(Date:8/23/2018)... ... , ... Visikol began its journey in late 2012 as an ... mentors, the Rutgers Technology Transfer team and Foundation Venture Capital Group, Visikol Inc was ... successful biotech company has been a circuitous path but was due in large part ...
(Date:8/21/2018)... Conn. (PRWEB) , ... August 21, 2018 , ... The ... 40, an annual recognition of the fastest growing technology companies in Connecticut. This year’s ... be held on Wednesday, October 3, at the Connecticut Convention Center in Hartford. A ...
(Date:8/17/2018)... ... August 16, 2018 , ... KCAS Bioanalytical and Biomarker ... expansion of their team. Dr. Dawn Dufield, Ph.D., joins KCAS as Director of ... LC-MS/MS group that will specialize in developing quantitative LC-MS/MS assays for biopharma molecules. ...
Breaking Biology Technology:
Cached News: